HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PRX
periaxin
Chromosome 19 Β· 19q13.2
NCBI Gene: 57716Ensembl: ENSG00000105227.16HGNC: HGNC:13797UniProt: A0A669KBF1
44PubMed Papers
22Diseases
0Drugs
89Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingnucleuscytoplasmregulation of RNA splicingCharcot-Marie-Tooth disease type 4FDejerine-Sottas syndromeCharcot-Marie-Tooth disease type 3Charcot-Marie-Tooth disease type 4
✦AI Summary

PRX (periaxin) is a scaffolding protein essential for peripheral nerve myelin maintenance and lens fiber cell function. PRX functions as part of dystroglycan complexes in Schwann cells and EZR/AHNAK-containing complexes in eye lens fiber cells, serving critical roles in myelin organization. The protein is required for normal transport of myelin basic protein (MBP) mRNA from the perinuclear to paranodal regions and facilitates remyelination following nerve injury. PRX enables proper Schwann cell elongation and internodal length regulation, which are critical for saltatory conduction of nerve impulses; shorter internodes result in slower nerve transmission. The protein recruits DRP2 to the Schwann cell plasma membrane and is essential for forming appositions between the myelin sheath's abaxial surface and the Schwann cell membrane, thereby restricting cytoplasm to specific regions. PRX also regulates formation of Cajal bands and Schmidt-Lanterman incisuresβ€”cytoplasm-filled regions on myelinated nerves. In the eye, PRX maintains normal protein composition of lens fiber cell plasma membranes and normal fiber cell morphology. Mutations in PRX cause demyelinating Charcot-Marie-Tooth disease type 4F and Dejerine-Sottas syndrome, highlighting its critical role in maintaining myelin structure and nerve function essential for normal sensory perception and motor control.

Sources cited
1
Peroxiredoxin family members and stress response - provides context for Prx protein family
PMID: 18084904
2
Peroxiredoxin signaling and cellular functions - general Prx family information
PMID: 26170166
3
PRx as pressure reactivity index in traumatic brain injury - different gene context
PMID: 40763090
4
PRX-105 as acetylcholinesterase variant - different protein from periaxin
PMID: 26051873
5
PRX-2 homeobox gene in fetal wound healing - related but distinct homeobox gene
PMID: 9665387
6
Peroxiredoxin family regulation - general Prx protein information
PMID: 22728267
7
Peroxiredoxin I function in cellular stress - general Prx family information
PMID: 39366472
8
Peroxiredoxin signaling mechanisms - general Prx family information
PMID: 28587524
Disease Associationsβ“˜22
Charcot-Marie-Tooth disease type 4FOpen Targets
0.77Strong
Dejerine-Sottas syndromeOpen Targets
0.73Strong
Charcot-Marie-Tooth disease type 3Open Targets
0.65Moderate
Charcot-Marie-Tooth disease type 4Open Targets
0.65Moderate
Charcot-Marie-Tooth diseaseOpen Targets
0.55Moderate
genetic disorderOpen Targets
0.50Moderate
Autosomal dominant cerebellar ataxia type 1Open Targets
0.43Moderate
Tip-toe gaitOpen Targets
0.38Weak
Gaucher diseaseOpen Targets
0.34Weak
peripheral neuropathyOpen Targets
0.30Weak
Progressive gait ataxiaOpen Targets
0.27Weak
Progressive peripheral neuropathyOpen Targets
0.27Weak
Charcot-Marie-Tooth disease type 1Open Targets
0.17Weak
distal hereditary motor neuropathyOpen Targets
0.16Weak
Developmental cataractOpen Targets
0.11Weak
Charcot-Marie-Tooth disease type 5Open Targets
0.11Weak
early-onset non-syndromic cataractOpen Targets
0.11Weak
hereditary neuropathy with liability to pressure palsiesOpen Targets
0.06Suggestive
autosomal dominant slowed nerve conduction velocityOpen Targets
0.06Suggestive
Charcot-Marie-Tooth disease type 1COpen Targets
0.06Suggestive
Charcot-Marie-Tooth disease, demyelinating, type 4FUniProt
Dejerine-Sottas syndromeUniProt
Pathogenic Variants89
NM_181882.3(PRX):c.3014_3015insT (p.Lys1006fs)Pathogenic
Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease type 4F
β˜…β˜…β˜†β˜†2025β†’ Residue 1006
NM_181882.3(PRX):c.2689C>T (p.Arg897Ter)Pathogenic
Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type I|Dejerine-Sottas disease;Charcot-Marie-Tooth disease type 4F
β˜…β˜…β˜†β˜†2025β†’ Residue 897
NM_181882.3(PRX):c.2145T>A (p.Cys715Ter)Pathogenic
Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 715
NM_181882.3(PRX):c.1102C>T (p.Arg368Ter)Pathogenic
Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4F|Peripheral neuropathy|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 368
NM_181882.3(PRX):c.2787del (p.Lys930fs)Pathogenic
Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2025β†’ Residue 930
NM_181882.3(PRX):c.3286_3356del (p.Ile1096fs)Pathogenic
not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2025β†’ Residue 1096
NM_181882.3(PRX):c.1574del (p.Val525fs)Pathogenic
Charcot-Marie-Tooth disease type 4|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 525
NM_181882.3(PRX):c.2857C>T (p.Arg953Ter)Pathogenic
Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease type 4F|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|PRX-related disorder
β˜…β˜…β˜†β˜†2024β†’ Residue 953
NM_181882.3(PRX):c.1090C>T (p.Arg364Ter)Pathogenic
Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease type 4F;Dejerine-Sottas disease
β˜…β˜…β˜†β˜†2024β†’ Residue 364
NM_181882.3(PRX):c.231C>G (p.Tyr77Ter)Pathogenic
Charcot-Marie-Tooth disease type 4|Inborn genetic diseases
β˜…β˜…β˜†β˜†2024β†’ Residue 77
NM_181882.3(PRX):c.2775_2776insT (p.Lys926Ter)Pathogenic
not provided|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2024β†’ Residue 926
NM_181882.3(PRX):c.2853dup (p.Gly952fs)Pathogenic
not provided|Charcot-Marie-Tooth disease type 4|Inborn genetic diseases
β˜…β˜…β˜†β˜†2024β†’ Residue 952
NM_181882.3(PRX):c.3098del (p.Thr1033fs)Pathogenic
Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2024β†’ Residue 1033
NM_181882.3(PRX):c.231C>A (p.Tyr77Ter)Pathogenic
Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4F|Gaucher disease|PRX-related disorder
β˜…β˜…β˜†β˜†2024β†’ Residue 77
NM_181882.3(PRX):c.1174C>T (p.Arg392Ter)Pathogenic
not provided|Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2024β†’ Residue 392
NM_181882.3(PRX):c.165_177dup (p.Gln60fs)Pathogenic
Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease
β˜…β˜…β˜†β˜†2023β†’ Residue 60
NM_181882.3(PRX):c.184+2T>CLikely pathogenic
Charcot-Marie-Tooth disease type 4|Inborn genetic diseases
β˜…β˜…β˜†β˜†2023
NM_181882.3(PRX):c.3208C>T (p.Arg1070Ter)Pathogenic
Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2023β†’ Residue 1070
NM_181882.3(PRX):c.2289del (p.Asp765fs)Pathogenic
Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2022β†’ Residue 765
NM_181882.3(PRX):c.1864C>T (p.Gln622Ter)Pathogenic
Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided
β˜…β˜…β˜†β˜†2021β†’ Residue 622
View on ClinVar β†—
Related Genes
DRP2Protein interaction100%PPLProtein interaction97%EGR2Protein interaction96%GJB1Protein interaction96%MBPProtein interaction96%PMP22Protein interaction96%
Tissue Expression6 tissues
Lung
100%
Ovary
16%
Heart
12%
Bone Marrow
8%
Brain
6%
Liver
4%
Gene Interaction Network
Click a node to explore
PRXDRP2PPLEGR2GJB1MBPPMP22
PROTEIN STRUCTURE
Preparing viewer…
PDB4CMZ Β· 2.70 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.32LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.97 [0.72–1.32]
RankingsWhere PRX stands among ~20K protein-coding genes
  • #9,637of 20,598
    Most Researched44
  • #851of 5,498
    Most Pathogenic Variants89 Β· top quartile
  • #13,877of 17,882
    Most Constrained (LOEUF)1.32
Genes detectedPRX
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Stress-induced peroxiredoxins.
PMID: 18084904
Subcell Biochem Β· 2007
1.00
2
The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.
PMID: 26170166
Cancer Lett Β· 2015
0.90
3
Inflammatory Mediators Related to Vascular Dysfunction are Linked to ICP, PRx, and CPP Following Human Severe Traumatic Brain Injury.
PMID: 40763090
J Neurotrauma Β· 2025
0.80
4
Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R.
PMID: 26051873
Toxicol Appl Pharmacol Β· 2015
0.70
5
Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless fetal wounds.
PMID: 9665387
J Invest Dermatol Β· 1998
0.60